Advertisement

Ad promo image large
  • Published Date

    August 13, 2021
    This ad was originally published on this date and may contain an offer that is no longer valid. To learn more about this business and its most recent offers, click here.

Ad Text

Business Insight Presented by Arlington Dermatology Biomedicine You hear the term bio- in association with many words that are commonly used in medicine. From simply biology to biologics, to biochemistry, to biomarkers, and similar. Bio- means life, living cells and molecules that take their origin in living organisms. Medicine has been attempting now for years to develop therapies that go back to the origination of medical problems. And it does it through developing of anti-cells, targeting the illness. How do we do it? How do we get to the origin of something so unique? Since the discovery of human genome in the early *90s, medical science has been able to 'code many diseases, including viruses and cancers. Do we know them all now? Absolutely not. Like everything in medical science, any science as a matter of fact, it is a project in progress and will remain so for years to come. Genomic sequencing is a reason why COVID-19 vaccines were developed so fast. Same sequencing and biomarker discovery treatment that will target just and only the are a reason why some cancers are being code of the disease, with no side effects treated with immunotherapy rather than chemotherapy. Immunotherapy delivers therapy called precision medicine. It lets us messaging to the body to produce anti-cells to kill cancer. Currently, we have several various types of immunotherapies developed body, and many other cells that build their for lung and colon cancers, and many organism and their disease. treatments are in the process of clinical trials. Hope is definitely on the horizon. When we conduct our clinical trials in not recognized by insurance industry. There dermatology, we do a lot of health monitoring is also a lot of misinterpretation of biologic of patients. We ask questions about their therapies and immunotherapies by doctors. general health, we do ECGS, we also do a lot Not all of the doctors keep up with the of blood testing. Some of the tests, especially overwhelming speed of medical progress and on longer studies, are biomarkers. We see no results of them on paper. They cannot be treatment changes almost every year. But good or bad, like cholesterol or sugar. Their biologic therapies and immunotherapies are results go far beyond of what we do in the safer and more effective than 'old' treatments. clinic. They deliver scientific information to Patients who happen to be in a position of medical scientists who coordinate the studies seeking medical advice for chronic diseases around the world, and they serve as a base to develop patterns in targeted treatment multiple opinions. What they should not do is for a disease. In other words, there is a hypothetical thought that many people with the same disease may present similar 'code remember that medicine is everchanging of the disease and analyzing thousands of science and not conspiracy. them will eventually allow to develop a or unnecessary symptoms. This is a dream tailor the treatment by studying biomarkers of an individual, their genes, proteins in their Development of individualized precision medicine is costly and, unfortunately, still it is easy to miss that standard of medical and cancer should ask questions and look for to listen to random advising from electronic media or social media. It is crucial to always Michael Bukhalo, MD Arlington Dermatology 5301 Keystone Court Rolling Meadows, IL 60008 Tel. 847 392 5440 | www.arlingtondermatology.net Business Insight Presented by Arlington Dermatology Biomedicine You hear the term bio- in association with many words that are commonly used in medicine. From simply biology to biologics, to biochemistry, to biomarkers, and similar. Bio- means life, living cells and molecules that take their origin in living organisms. Medicine has been attempting now for years to develop therapies that go back to the origination of medical problems. And it does it through developing of anti-cells, targeting the illness. How do we do it? How do we get to the origin of something so unique? Since the discovery of human genome in the early *90s, medical science has been able to 'code many diseases, including viruses and cancers. Do we know them all now? Absolutely not. Like everything in medical science, any science as a matter of fact, it is a project in progress and will remain so for years to come. Genomic sequencing is a reason why COVID-19 vaccines were developed so fast. Same sequencing and biomarker discovery treatment that will target just and only the are a reason why some cancers are being code of the disease, with no side effects treated with immunotherapy rather than chemotherapy. Immunotherapy delivers therapy called precision medicine. It lets us messaging to the body to produce anti-cells to kill cancer. Currently, we have several various types of immunotherapies developed body, and many other cells that build their for lung and colon cancers, and many organism and their disease. treatments are in the process of clinical trials. Hope is definitely on the horizon. When we conduct our clinical trials in not recognized by insurance industry. There dermatology, we do a lot of health monitoring is also a lot of misinterpretation of biologic of patients. We ask questions about their therapies and immunotherapies by doctors. general health, we do ECGS, we also do a lot Not all of the doctors keep up with the of blood testing. Some of the tests, especially overwhelming speed of medical progress and on longer studies, are biomarkers. We see no results of them on paper. They cannot be treatment changes almost every year. But good or bad, like cholesterol or sugar. Their biologic therapies and immunotherapies are results go far beyond of what we do in the safer and more effective than 'old' treatments. clinic. They deliver scientific information to Patients who happen to be in a position of medical scientists who coordinate the studies seeking medical advice for chronic diseases around the world, and they serve as a base to develop patterns in targeted treatment multiple opinions. What they should not do is for a disease. In other words, there is a hypothetical thought that many people with the same disease may present similar 'code remember that medicine is everchanging of the disease and analyzing thousands of science and not conspiracy. them will eventually allow to develop a or unnecessary symptoms. This is a dream tailor the treatment by studying biomarkers of an individual, their genes, proteins in their Development of individualized precision medicine is costly and, unfortunately, still it is easy to miss that standard of medical and cancer should ask questions and look for to listen to random advising from electronic media or social media. It is crucial to always Michael Bukhalo, MD Arlington Dermatology 5301 Keystone Court Rolling Meadows, IL 60008 Tel. 847 392 5440 | www.arlingtondermatology.net